HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) for GRACEWAY PHARMACEUTICALS
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 21, 2008 | $80,000 | Replaced |
| 2nd Quarter - Amendment | Feb 11, 2009 | $80,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Extension of time to transition asthma inhaler from CFC to non-CFC form.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN M MCAULIFFE New | Minority Leader Richard A. Gephardt |
| CANDIDA PEROTTI WOLFF New | for Legislative Affairs |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.